Transcode Therapeutics Inc Financial Flexibility Index
Transcode Therapeutics Inc financial flexibility index. Transcode Therapeutics Inc (RNAZ) has a Financial Flexibility Index of -0.43x as of June 2026. Free cash flow of $-5.40 Million (operating CF $-5.40 Million minus capex $0.00) represents 0% of total liabilities ($12.65 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Transcode Therapeutics Inc (2018–2025)
Financial flexibility index of Transcode Therapeutics Inc from 2018 to 2025. Historical Financial Flexibility Index trend for Transcode Therapeutics Inc across 8 annual periods. Check RNAZ operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Transcode Therapeutics Inc Financial Flexibility Index by Year (2018–2025)
Transcode Therapeutics Inc financial flexibility index by year from 2018 to 2025. Year-by-year free cash flow to debt coverage for Transcode Therapeutics Inc. For the full cash flow conversion analysis, see RNAZ cash generation efficiency.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.13x | $-19.51 Million | $-19.52 Million | $152.06 Million | ▲ +91.0% |
| 2024 | -1.43x | $-13.31 Million | $-13.34 Million | $9.31 Million | ▲ +72.0% |
| 2023 | -5.11x | $-18.04 Million | $-18.07 Million | $3.53 Million | ▼ -41.9% |
| 2022 | -3.60x | $-15.66 Million | $-15.76 Million | $4.35 Million | ▼ -82.1% |
| 2021 | -1.98x | $-5.01 Million | $-5.27 Million | $2.53 Million | ▼ -3607.0% |
| 2020 | -0.05x | $-238.15K | $-492.97K | $4.46 Million | ▲ +72.4% |
| 2019 | -0.19x | $-253.69K | $-508.51K | $1.31 Million | ▼ -210.0% |
| 2018 | -0.06x | $-44.75K | $-299.57K | $718.61K | — |